0Suppliers
14Customers
1Debt Items
11Related Chains

Source-Backed Evidence Depth

Maravai LifeSciences Holdings, Inc. (MRVI) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

16Total relationships
2Distinct source URLs
3High confidence
0.685Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Maravai LifeSciences Holdings, Inc. Suppliers

No suppliers on recordMaravai LifeSciences Holdings, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Maravai LifeSciences Holdings, Inc. Customers

TickerNameConfidenceEvidence
NACALAI-USA-INC NACALAI-USA-INC 90% Nacalai USA, Inc. * * * 12.0 %
BNTX BioNTech SE 72% Reciprocal relationship from BNTX graph: Reciprocal relationship from MRVI graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MRVI graph: able were $ million during the year…
BNTX BioNTech SE 72% able were $ million during the year ended December 31, 2024 . Write-offs of accounts receivable were significant during the years ended December 31, 2023 and 2022. Recoveri es were significant during…
GTCR-LLC GTCR-LLC 62% chnology on which our products and services are based. • Our use of Artificial Intelligence technologies, including Machine Learning, and business, compliance, and reputational challenges that may re…
INSTEAD-TOPCO-LLC INSTEAD-TOPCO-LLC 62% ue Measurements The following tables summarize the Company’s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy as of the p…
LONG-TERM-DEBT-CREDIT-AGREEMENT-MARAVAI-INTERMED LONG-TERM-DEBT-CREDIT-AGREEMENT-MARAVAI-INTERMED 62% ue Measurements The following tables summarize the Company’s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy as of the p…
MARAVAI-LIFE-SCIENCES-HOLDINGS MARAVAI-LIFE-SCIENCES-HOLDINGS 62% chnology on which our products and services are based. • Our use of Artificial Intelligence technologies, including Machine Learning, and business, compliance, and reputational challenges that may re…
MARAVAI-LIFE-SCIENCES-HOLDINGS-LLC MARAVAI-LIFE-SCIENCES-HOLDINGS-LLC 62% chnology on which our products and services are based. • Our use of Artificial Intelligence technologies, including Machine Learning, and business, compliance, and reputational challenges that may re…
MARAVAI-TOPCO-HOLDINGS-LLC MARAVAI-TOPCO-HOLDINGS-LLC 62% chnology on which our products and services are based. • Our use of Artificial Intelligence technologies, including Machine Learning, and business, compliance, and reputational challenges that may re…
MOLECULAR-ASSEMBLIES-INC MOLECULAR-ASSEMBLIES-INC 62% alue on a recurring basis. Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and account…
MYCHEM-LLC MYCHEM-LLC 62% our industry or across different industries. Components of Results of Operations Revenue Our revenue consists primarily of product revenue and, to a much lesser extent, service revenue. We generated …
TOPCO-LLC-OPERATING-AGREEMENT-TOPCO-LLC TOPCO-LLC-OPERATING-AGREEMENT-TOPCO-LLC 62% uring the three months ended March 31, 2026 and 2025, the Company did not recognize a material amount of revenue that was included in the contract liabilities balances as of December 31, 2025 and 202…
TRA-TOPCO-LLC TRA-TOPCO-LLC 62% our estimated U.S. federal, state and local income tax rates, will be included in the Company’s Annual Report on Form 10-K for the year ending December 31, 2026 when such impacts are determinable. As…
UNIT-HOLDERS-THE-LLC UNIT-HOLDERS-THE-LLC 62% ue Measurements The following tables summarize the Company’s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy as of the p…

Maravai LifeSciences Holdings, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
MRVI-DEBT Debt stack $147.1M 90% Market cache reports total debt of $147.1M.

Maravai LifeSciences Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Maravai LifeSciences Holdings, Inc..

Maravai LifeSciences Holdings, Inc. Ownership

HolderNameConfidenceEvidence
MRVI-OWNER-GTCR-LLC GTCR LLC 90% 13F overlay lists GTCR LLC as top holder; 161 tracked holders.

Maravai LifeSciences Holdings, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BNTX BioNTech SE 100.00 1 ['customer']
CBIO Crescent Biopharma, Inc. 50.00 2
BCAX Bicara Therapeutics Inc. 50.00 2
EVAX Evaxion A/S 50.00 2
BMY Bristol-Myers Squibb Company 50.00 2
TNXP Tonix Pharmaceuticals Holding Corp. 50.00 2
MGNX MacroGenics, Inc. 50.00 2
SMMT Summit Therapeutics Inc. 50.00 2
ROIV Roivant Sciences Ltd. 50.00 2
AUTL Autolus Therapeutics plc 50.00 2
MTNB Matinas BioPharma Holdings, Inc. 50.00 2
🔐
MRVI
Unlock MRVI Supply Chain Data
Verified relationships include:
NACALAI-USA-INCNACALAI-USA-INCCustomer90%
BNTXBioNTech SECustomer72%
+12 more relationships locked
Subscribe — View plans →